What is the company’s current cash position and liquidity after the loss? | GFF (Aug 06, 2025) | Candlesense
GFF

What is the company’s current cash position and liquidity after the loss?

The press release you referenced reports the third‑quarter revenue, net loss and the impairment charge, but it does not disclose any figures for Griffon Corporation’s cash balance or other liquidity metrics (e.g., cash‑equivalents, available borrowing capacity, revolving‑credit commitments, or debt covenants).

Because those details are absent from the excerpt you provided, I can’t give you a concrete number for the company’s cash position or liquidity after the $120.1 million loss.

What to do next

  1. Read the full earnings release – The complete 10‑Q filing or the full Business Wire release will normally contain a “Liquidity and Capital Resources” or “Cash Flow” section that states:

    • Cash and cash equivalents at quarter‑end
    • Net cash provided by (or used in) operating, investing and financing activities
    • Any changes to revolving‑credit facilities, term loans, or other financing arrangements

  2. Check the company’s Form 10‑Q – Griffon files quarterly reports with the SEC (Form 10‑Q). The “Management’s Discussion and Analysis” (MD&A) and “Consolidated Balance Sheet” sections will give you the exact cash‑on‑hand figure and a breakdown of its liquidity position.

  3. Investor Relations site – Most public companies post the earnings release, presentation slides, and accompanying Q&A on their IR website. Look for a slide titled “Liquidity & Capital Resources” or similar.

If you obtain the full release or the 10‑Q and share the relevant excerpt, I can help interpret the numbers and explain how the loss and impairment charge impacted Griffon’s cash and overall liquidity.

Other Questions About This News

Are there any covenant or debt refinancing risks triggered by the loss? How will the net loss and per‑share loss impact the stock price in the short term? How does the 5% revenue decline compare to consensus expectations and analyst estimates? What operational or cost‑saving measures is management considering to improve profitability? What is the expected impact on the P/E ratio and valuation multiples? Are there any upcoming catalysts (e.g., new product launches, acquisition targets) that could offset the loss? What is the outlook for the impaired segment (Hun) – are there plans to exit, restructure, or sell the business? How will this loss affect the company’s credit rating and borrowing capacity? What is the guidance for FY2025 revenue, earnings, and cash flow after this loss? What does management say about the timing and magnitude of future impairments or write‑downs? How does this loss affect the company's long‑term growth strategy? How does this quarter’s performance compare to peer companies in the same sector? What are the specific reasons behind the $217.2 million impairment charge and how does it affect future earnings? Does the company plan to adjust dividends or share buybacks in response to the loss?